Navigation Links
Cardiac Science Releases New Cardiac Rehabilitation System
Date:10/2/2007

Enhances connectivity to HIS and EMR solutions

BOTHELL, Wash., Oct. 2 /PRNewswire-FirstCall/ -- Cardiac Science Corporation, (Nasdaq: CSCX), a global leader in advanced cardiac monitoring and defibrillation products, announced today the launch of the Quinton Q-Tel RMS(R) 3.0. This significant advance to the trusted Quinton line of cardiac rehabilitation systems offers several connectivity upgrades and workflow advancements to enable the best possible treatment decisions in cardiac rehabilitation.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO)

Some of the Q-Tel 3.0 key advancements include:

-- Bi-directional connectivity to a hospital's EMR and HIS system.

-- Improved tracking of HIPAA compliance requirements through user

activity logs.

-- Session Recovery advancements to prevent the loss of patient data due

to power interruption or application error.

-- Q-Tel Pocket Assistant for wireless session management, enabling users

to customize data entry parameters and formats for resting, exercise

and recovery data by program type.

"Quinton Q-Tel connects the clinician to the enterprise EMR, the patient, the medical staff and the latest technology," said Rene Mitchell, director of diagnostic marketing at Cardiac Science. "In addition to offering nurses and exercise physiologists the reliable, high-performance rehab technology they have come to expect from the Q-Tel system, Q-Tel 3.0 improves workflow efficiency with enhanced connectivity, allowing the rehab department to connect to the hospital's HIS and EMR system. These enhancements were in direct response to our customers' feedback on what would enable them to make the best possible treatment decisions, and manage their workflow most effectively."

Frost & Sullivan, the global growth consulting company, has awarded Cardiac Science its 2007 award for Global Excellence in ECG Monitoring, recognizing Cardiac Science's superior leadership and vision to provide superior healthcare solutions in the cardiac monitoring market.

For more information about the Q-Tel RMS 3.0 System, please call 800.679.8703.

About Cardiac Science Corporation

Cardiac Science is truly at the heart of saving lives. The Company develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including AEDs, electrocardiographs, stress test systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, patient monitor -- defibrillators and cardiology data management systems. Cardiac Science also sells a variety of related products and consumables, and provides a comprehensive portfolio of training, maintenance and support services. The Company is the successor to various entities that have owned and operated cardiology-related businesses that sold products under the trusted brand names Burdick(R), Powerheart(R), and Quinton(R). Cardiac Science is headquartered in Bothell, WA, and also has operations in Lake Forest, California; Deerfield, Wisconsin; Shanghai, China; Copenhagen, Denmark; and Manchester, United Kingdom.

Forward Looking Statements

This press release contains forward-looking statements. The words "believe," "expect," "intend," anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. Forward looking statements in this press release include those that infer or imply that our Q-Tel RMS 3.0 and other products will be successful in the marketplace, resulting in increasing revenues and profits. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause or contribute to such varying results and other risks are more fully described in the 10-k filed by Cardiac Science Corporation for the year ended December 31, 2006.

The statements in this press release speak as of the date of the release, and Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.

Company Contact:

Mike Matysik

Cardiac Science Corporation

Sr. Vice President and CFO

425-402-2009

Investor Contact:

EVC Group, Inc.

Douglas Sherk/Jenifer Kirtland

415-896-6820

Media Contact:

EVC Group, Inc.

Jen Saunders

646-201-5431


'/>"/>
SOURCE Cardiac Science Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Thyroid hormone treatment hastens recovery after cardiac surgery
2. Gene HPA-2 Met linked to cardiac arrest
3. Defibrillators In Public Places Will Help Cardiac Patients
4. Supplement helps cardiac surgery
5. Cardiac diseases develop early
6. Latest device for cardiac revival under test
7. Bone marrow stem cells may help repair cardiac tissues
8. Heart problems detected better with a Cardiac MRI
9. Cardiac events better treated with intense cholesterol-lowering regime
10. Sudden Cardiac Death due to inherited Heart Disease
11. Vasopressin Found To Boost Survival In Sudden Cardiac arrest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Lehi, Utah (PRWEB) , ... January 17, 2017 ... ... provider of accredited, online continuing education for EMS and firefighting professionals, has released ... Training (VILT) Solution. These new courses are taught live in an online classroom ...
(Date:1/17/2017)... TEXAS (PRWEB) , ... January 17, 2017 , ... ... provider, today announced its partnership with Sigfox in the U.S.A. to ... cities nationwide including new offerings on large-scale environmental sensor deployments such as ...
(Date:1/17/2017)... ... January 17, 2017 , ... Livionex, Inc., a Silicon Valley healthcare company focused ... study for its dental gel that shows significant reduction in plaque levels and gum ... The study was conducted at the Beckman Laser Institute at UC Irvine and has ...
(Date:1/17/2017)... , ... January 17, 2017 , ... ... private companies and ranked among the top US security companies for consecutive years, ... This announcement brings a year-long independent board nomination process to a close ...
(Date:1/16/2017)... ... January 17, 2017 , ... ... an internationally recognized leader in the fast-casual category, announces a hearty and wholesome ... Good Egg Breakfast Sandwich, Turkey Mash-Up Sandwich, Cranberry Crunch & Honey Parfait, Slow ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... Jan. 17, 2017 EU5 Glucose Monitoring Market ... report, "EU5 Glucose Monitoring Market Outlook to 2022", provides ... The report provides value, in millions of US dollars, ... segments - Blood Glucose Meters, Blood Glucose Test Strips ... and distribution shares data for each of these market ...
(Date:1/17/2017)... Jan. 17, 2017 Paragon Bioservices received a ... development services for a variety of National ... medical product development activities. The IDIQ mechanism will ... for task order awards up to $159 million. ... manufacturing and process development of biopharmaceuticals, is one ...
(Date:1/17/2017)... 2017  Pennsylvania Secretary of Health Dr. ... marijuana growers/processors and dispensaries are now available on ... Permit applications will be accepted from February 20 ... an important step forward in getting this valuable ... Murphy said. "We,ve developed a thorough application that ...
Breaking Medicine Technology: